President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.
The U.S. Health Resources and Services Administration’s Office of Pharmacy Affairs will get $12.2 million this fiscal year, $1 million more than in fiscal 2022, according to a spending table in a congressional explanatory report that went with the bill. The Biden administration sought $17.2 million for OPA.
President Biden on Dec. 29 signed a $1.7 trillion omnibus appropriations bill for fiscal year 2023 that gave the 340B drug pricing program a slight funding boost.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
